Lantern Pharma announces up to $8M registered direct offering
Lantern Pharma announces up to $8M registered direct offering TradingView
Covered in this story
What has happened since
- Lantern Pharma is down 13.4% since this was published, 6 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $LTRN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Lantern Pharma →Summary aggregated from TradingView's public RSS feed. The full reporting belongs to TradingView — please read it on their site.